<?xml version="1.0" encoding="UTF-8"?>
<ref id="B54-molecules-26-02377">
 <label>54.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Anasamy</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Abdul</surname>
    <given-names>A.B.</given-names>
   </name>
   <name>
    <surname>Sukari</surname>
    <given-names>M.A.</given-names>
   </name>
   <name>
    <surname>Abdelwahab</surname>
    <given-names>S.I.</given-names>
   </name>
   <name>
    <surname>Mohan</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Kamalidehghan</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Azid</surname>
    <given-names>M.Z.</given-names>
   </name>
   <name>
    <surname>Muhammad Nadzri</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Andas</surname>
    <given-names>A.R.J.</given-names>
   </name>
   <name>
    <surname>Kuan Beng</surname>
    <given-names>N.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>A Phenylbutenoid dimer, 
   <italic>cis</italic>-3-(3′,4′-dimethoxyphenyl)-4-[(
   <italic>E</italic>)-3′′′,4′′′-dimethoxystyryl]cyclohex-1-ene, exhibits apoptogenic properties in T-acute lymphoblastic leukemia cells via induction of p53-independent mitochondrial signalling pathway
  </article-title>
  <source>Evid. Based Complement. Alternat. Med.</source>
  <year>2013</year>
  <volume>2013</volume>
  <fpage>939810</fpage>
  <pub-id pub-id-type="doi">10.1155/2013/939810</pub-id>
  <?supplied-pmid 23710242?>
  <pub-id pub-id-type="pmid">23710242</pub-id>
 </element-citation>
</ref>
